aztreonam has been researched along with Shock, Septic in 3 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam use was also associated with increased utilization of aminoglycosides (28." | 1.62 | Empiric aztreonam is associated with increased mortality compared to beta-lactams in septic shock. ( Anderson, WE; Hammer, J; Heffner, AC; Jaffa, RK; Medaris, LA; Pillinger, KE, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benchetrit, L | 1 |
| Mathy, V | 1 |
| Armand-Lefevre, L | 1 |
| Bouadma, L | 1 |
| Timsit, JF | 1 |
| Miller, J | 1 |
| Hall, B | 1 |
| Wilson, K | 1 |
| Cobian, J | 1 |
| Jaffa, RK | 1 |
| Hammer, J | 1 |
| Medaris, LA | 1 |
| Anderson, WE | 1 |
| Heffner, AC | 1 |
| Pillinger, KE | 1 |
3 other studies available for aztreonam and Shock, Septic
| Article | Year |
|---|---|
Successful treatment of septic shock due to NDM-1-producing Klebsiella pneumoniae using ceftazidime/avibactam combined with aztreonam in solid organ transplant recipients: report of two cases.
Topics: Aged; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Com | 2020 |
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Centers for Medicare and Medi | 2020 |
Empiric aztreonam is associated with increased mortality compared to beta-lactams in septic shock.
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; APACHE; Aztreonam; beta-Lactams; Ce | 2021 |